1. Home
  2. SVC vs OMER Comparison

SVC vs OMER Comparison

Compare SVC & OMER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVC
  • OMER
  • Stock Information
  • Founded
  • SVC 1995
  • OMER 1994
  • Country
  • SVC United States
  • OMER United States
  • Employees
  • SVC N/A
  • OMER N/A
  • Industry
  • SVC Real Estate Investment Trusts
  • OMER Biotechnology: Pharmaceutical Preparations
  • Sector
  • SVC Real Estate
  • OMER Health Care
  • Exchange
  • SVC Nasdaq
  • OMER Nasdaq
  • Market Cap
  • SVC 453.3M
  • OMER 532.0M
  • IPO Year
  • SVC N/A
  • OMER 2009
  • Fundamental
  • Price
  • SVC $2.69
  • OMER $9.18
  • Analyst Decision
  • SVC Buy
  • OMER Buy
  • Analyst Count
  • SVC 2
  • OMER 4
  • Target Price
  • SVC $5.25
  • OMER $22.50
  • AVG Volume (30 Days)
  • SVC 1.5M
  • OMER 436.6K
  • Earning Date
  • SVC 02-26-2025
  • OMER 03-31-2025
  • Dividend Yield
  • SVC 1.49%
  • OMER N/A
  • EPS Growth
  • SVC N/A
  • OMER N/A
  • EPS
  • SVC N/A
  • OMER N/A
  • Revenue
  • SVC $1,884,419,000.00
  • OMER N/A
  • Revenue This Year
  • SVC N/A
  • OMER N/A
  • Revenue Next Year
  • SVC N/A
  • OMER N/A
  • P/E Ratio
  • SVC N/A
  • OMER N/A
  • Revenue Growth
  • SVC N/A
  • OMER N/A
  • 52 Week Low
  • SVC $2.29
  • OMER $2.61
  • 52 Week High
  • SVC $7.73
  • OMER $13.60
  • Technical
  • Relative Strength Index (RSI)
  • SVC 48.69
  • OMER 51.19
  • Support Level
  • SVC $2.55
  • OMER $9.06
  • Resistance Level
  • SVC $2.69
  • OMER $9.43
  • Average True Range (ATR)
  • SVC 0.13
  • OMER 0.52
  • MACD
  • SVC -0.01
  • OMER 0.08
  • Stochastic Oscillator
  • SVC 43.24
  • OMER 52.25

About SVC Service Properties Trust

Service Properties Trust is a real estate investment trust that owns hotel properties. These properties are located in the United States, along with Canada and Puerto Rico. The company operates through its hotel investment unit and net lease investments. The firm derives the majority of its revenue from the hotel real estate investments unit. The hotels are distinguished between their service levels, which include full service, select service, and extended stay; and chain scale, which includes luxury, upper upscale, upscale, upper midscale, and midscale. The hotels are extended stay or upscale. Some of the hotel brands include Courtyard by Marriott, Royal Sonesta, Crowne Plaza Hotels & Resorts, and Hyatt Place.

About OMER Omeros Corporation

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The lead drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.

Share on Social Networks: